INTRODUCTION
The term 'mycoplasmoses' designates infectious diseases due to mycoplasmas, which are known to be the smallest prokaryotes with autonomous replication. In fact, the general term 'mycoplasma' is a trivial name, referring to a group of microorganisms which differ from other bacteria by, among other things, lacking a cell wall. This was the reason for creating a new class, named Mollicutes (from the Latin mollis [soft] and cutis [skin] ). This class comprises four orders, with different families and genera totalling approximately 160 species, which are parasitical to a broad range of hosts, from humans to animals, insects and plants (Table I) (2) . The list is far from exhaustive, as new species are currently being described and uncultured mycoplasmalike plant organisms, the phytoplasmas, are considered as Mollicutes too. 
HABITAT AND ANIMAL HOSTS
Animal mycoplasmas are essentially extracellular parasites with a special affinity for mucous membranes, where they exist as commensals or pathogens. Anaerobic anaeroplasmas have so far been found in the bovine and ovine rumina. Pathogenic mycoplasmas have a pronounced affinity for certain tissues or organs, and a predilection for the respiratory system, the urogenital tract, the mammary gland or serous membranes (4, 5) .
The range of animal hosts which are known to harbour mycoplasmas varies from non-human primates to domestic animals, including domestic birds and pets, laboratory animals, wild mammals, wild birds, fish and reptiles (Table II) (6) . 
It has long been recognised that mycoplasmas are, at least in regard to the pathogenic species, highly host-specific. In fact, most mycoplasmas are adapted to a main host in which they are commonly pathogenic. Sometimes they colonise other hosts, often without fully expressing their pathogenicity. For example, Mycoplasma gallisepticum has been isolated from cattle, M. pulmonis from horses, M. bovigenitalium from pigs and M. mycoides subsp. mycoides SC (small colony) from sheep and goats.
PATHOGENICITY
As mucous membrane parasites, mycoplasmas adhere firmly to epithelial cells. The molecular biology of adhesion is well known in regard to human mycoplasmas, but this is not so for animal species (4, 5) . Exceptions are M. gallisepticum, M. pulmonis and M. hyopneumoniae, for which evidence of adhesion structures has been established. Adhesion is a prerequisite for colonisation and, consequently, for infection. It has been suggested that by-products of mycoplasmal metabolism, such as hydrogen superoxide and superoxide radicals, may be toxic to the host cell cilia or to the cell membranes. The possible role of extracellular enzymes has still not been investigated and no defined specific toxin has been identified yet. The role of the capsules seen in some mycoplasmas, particularly the galactan of M. mycoides subsp. mycoides, is not clear either. There is evidence in many cases that the activation of the host immune system plays a major role in the pathogenesis of mycoplasmoses. The mitogenic stimulation of lymphocytes, antiphagocytic activity, immunosuppressive effects and auto-immune phenomena have been observed for many years in a variety of animals. In many instances, these circumstances may explain a certain characteristic pathomorphology. Recently performed studies indicate that the interaction of mycoplasmas with macrophages and monocytes induces the production of proinflammatory cytokines, such as the tumour necrosis factor a, interleukins and interferon y. Particular attention must be paid to the mycoplasma membrane lipoproteins and certain lipids, which induce cytokine secretion by a mechanism distinct from that of bacterial lipopolysaccharides (4, 5) .
The role of superantigens is probably essential for the activation of the immune system. This has been demonstrated with a cytoplasmic component of M. arthritidis (MAM). Superantigens are thought to be of great significance in the development or enhancement of auto-immune reactions.
The surface antigenic variation systems, demonstrated in numerous pathogenic human and animal mycoplasmas, represent another aspect of pathogenicity. Most of the systems consist of very immunogenic lipoproteins. Through reversible switching of the expression and modification of major antigens, the surface antigenic variation allows the mycoplasma to escape rapid elimination by the immune system and, consequently, to persist in the host.
In spite of these different mechanisms of pathogenicity, mycoplasmas are not considered highly virulent 'per se'. They provoke chronic diseases rather than fulminate diseases. The difficulty of reproducing mycoplasmoses by experimental infection cannot be explained exclusively by the rapid loss of virulence during in vitro passages. This difficulty also highlights the important role played by predisposing factors, in regard to the environment or to the host.
Thus, it appears that medically and economically important animal mycoplasmoses are essentially herd problems. Obviously, there is no basic difference between the situation of extensive breeding in developing countries and that of intensive animal production in industrialised countries. In both cases, the respective particularities favour the expression of mycoplasmoses. Since animal mycoplasmoses are, as a rule, chronic diseases with high morbidity and relatively low mortality, apparently healthy carriers play a dominant role in the epidemiology of mycoplasmoses.
Among the more than 160 known species of the Mollicutes, a relatively small number of the genera Mycoplasma, Ureaplasma and Acholeplasma have been isolated from animals, and few of them have been established as pathogenic (Table II) . The most important pathogens are found in the mycoides 'cluster' with six species, among them the agents of contagious bovine pleuropneumonia (CBPP), contagious caprine pleuropneumonia (CCPP), and agents of pneumonia, arthritis and mastitis in goats and sheep. Another group of related mycoplasmas plays a considerable role, with M. agalactiae (contagious agalactia of goats and sheep) and M. bovis (mastitis, pneumonia and arthritis in cattle). M. hyopneumoniae, the agent of enzootic pneumonia in pigs, and M. gallisepticum, the agent of chronic respiratory disease (CRD) in poultry, are the classic farm animal mycoplasmoses of socio-economic importance.
Many other mycoplasma species, which commonly occur as commensals on mucous membranes, are sporadically associated with pathological conditions. They often appear either together with other bacterial and viral infections or in particular situations in which the host has debilitated defences. Consequently, many Mycoplasma and Ureaplasma species with poorly defined pathogenicity may be involved in diseases of the respiratory and urogenital tract of ruminants, horses, dogs, cats, laboratory animals and various wild animals. The keratoconjunctivitis due to M. conjunctivae occupies an intermediate situation. This is definitely a herd infection which needs particular predisposing factors, such as crowding or climatic factors. This infection does not have a great socio-economic impact in regard to sheep, but may lead to dramatic outbreaks in wildlife (chamois, ibex).
EPIDEMIOLOGICAL FEATURES
In considering the manifestation of animal mycoplasmoses, it is necessary to distinguish between the sporadic outbreak of disease and the epidemic or endemic occurrence, with socio-economic consequences.
As mentioned before, many animal mycoplasmoses are sporadic diseases, affecting several animal species. These diseases are limited to one animal or to a unique or restricted epidemiological situation affecting a group of animals. Considering the number of mycoplasma species and the number of hosts involved, the majority of animal mycoplasmoses are doubtless sporadic ones.
Generally speaking, crowding together of animals of different origins is the main factor favouring mycoplasmosis. Transmission takes place by direct contact, often through the air-borne route, through milking in the case of mastitis, or through the genital route, i.e. eggs. The severity of symptoms and the propagation of infection depend on the pathogenicity of the particular mycoplasma species or the particular strain, as well as on the joint action of predisposing factors.
TREATMENT, CONTROL AND PREVENTION
Since mycoplasmas lack a cell wall, they are naturally resistant to ß-lactam antibiotics (the penicillin group), but sensitive to numerous other antibacterial drugs. The most active drugs are the macrolides (erythromycin, spiramycin and tylosine), tetracyclines, quinolones and chloramphenicol. Therapeutic success depends on the localisation of infection and on the drug application procedures. Antibiotic therapy commonly provides a rapid improvement of the clinical picture and, in individual and sporadic cases, may cure the infection. In herd infections, systematic treatment of all animals can eliminate the infection under certain conditions and at least for the short term.
The control of animal mycoplasmoses is an important objective of veterinary medicine at present, particularly with regard to infections of socio-economic importance. In order to identify the problem with efficient diagnostic tools, well-organised epidemiological surveillance networks are a prerequisite. The situation of mycoplasmoses in cattle, sheep and goats was thoroughly discussed in the 62nd General Session of the Office International des Epizooties (OIE) in Paris (3). The Delegates approved a resolution (No. XI), recommending that Member Countries set up surveillance systems, specialised laboratories and a national reference laboratory for mycoplasmoses. Furthermore, the resolution suggested that improvement of the diagnosis of mycoplasmoses was vital, attaching priority to research in this field. The microbiological diagnosis of mycoplasmoses is difficult, and the introduction of efficient diagnostic tests will depend, to a large extent, on new technological developments, which are urgently needed.
Numerous vaccines have been developed to prevent mycoplasmoses, but their efficacy is often doubtful or imperfectly evaluated. This is mainly due to the immunogenic property of the vaccine and, furthermore, to the type of immunity induced by the vaccine at the site of infection. Apart from vaccines against CBPP, which provide momentary protection within endemic areas, the role of vaccination as an efficient way of preventing mycoplasmoses remains controversial. In fact, the eradication of the disease should be the principal objective in the control of endemic or epidemic mycoplasmoses. It is difficult to achieve eradication programmes, as mycoplasmoses are chronic, very contagious, and clinically not often apparent, and the overall diagnosis of the disease is highly complex at present. Such problems imply the need for very efficient epidemiological surveillance with good laboratory support. Preventing the introduction of undesirable mycoplasmoses is based primarily on the control of animal movement and a permanent system of surveillance. In this respect, the OIE and the Veterinary Services of the Member Countries are very active and have already proved their competence in providing efficient structures.
CONCLUDING REMARKS
The research into the molecular biology and genetics of Mollicutes has provided an enormous amount of information in the last decade (4, 5) . Such research has stimulated renewed interest in medical and veterinary mycoplasmology. At present, relatively few groups are active in research into mycoplasmas. The main topics of basic research are genetics (molecular phylogeny, genetic variation, gene structures, gene mapping, gene cloning and expression, etc.), biochemistry and physiology (the variability of surface proteins, surface carbohydrates, membrane fusion, enzymatic activities, etc.) and immunology (the induction of cytokines, superantigens, mitogens, etc.). This research, on the one hand, affords basic knowledge of the biology of these poorly understood organisms and, on the other hand, allows new technological developments for diagnostic tools. Hence, many new DNA amplification methods (such as polymerase chain reaction) and probes have been proposed for the diagnosis and identification of the most important mycoplasmas. Some new serological tests, based principally on enzyme-linked immunosorbent assay and monoclonal antibodies, have also been developed. It is highly desirable to encourage research into the development of simple and rapid diagnostic tools. Furthermore, it is urgent that such methods be not only standardised and validated within laboratories or by the manufacturers, but also evaluated and validated in different field situations. To this purpose, precise epidemiological data should be made available. An efficient control and surveillance programme can only be realised under these circumstances.
Therefore, research, diagnosis and field applications must be better organised and co-ordinated. A COST (European co-operation in the field of scientific and technical research) Action (No. 826), which groups sixteen countries from the European Union with other affiliated European countries, aims to bring together all scientists active in the field of ruminant mycoplasmoses (1) . The objective is to promote and co-ordinate research, to stimulate new technological developments in the diagnosis of these diseases and to evaluate the practicability of the different diagnostic procedures in field situations. This very rational way of achieving progress in understanding the epidemiology of mycoplasmoses and of proposing efficient methods of control and prevention is in accord with the efforts of the OIE and the Veterinary Services. 
